跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENVIMA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LENVIMA
Authorized
STANDARD
LENVIMA
EISAI LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
32c14d77fed79bbf
Company
EISAI LIMITED
Type
Standard
Approval Details
Approval Id
32c14d77fed79bbf
Drug Approval Canada Name
LENVIMA
Product Name
LENVIMA
Status
Marketed
Status Date
2019-10-21
Original Market Date
2019-10-21
Din
02484056
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EX08 LENVATINIB
Atc Name
l 01 ex 08
Aig Number
0157671007
Company Name
EISAI LIMITED
Company Address
6925 Century Ave, Suite 701, Mississauga, Ontario, Canada, L5N 7K2
Company Detail Path
/organization/eisai-limited
Company Information
Pharmaceutical Company Name
EISAI LIMITED
Country Name
Ireland
Address
TEN EARLSFORT TERRACE
Active Ingredients
LENVATINIB (LENVATINIB MESYLATE)
4 MG / DOSE
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
32c14d77fed79bbf
Type
Standard
Back to Health Canada Approvals